secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHINA PHARMA HOLDINGS, INC. (CPHI)
CIK:        0001106644
Form:       8-K
Filed at:   2024-12-13T23:59:59+00:00
Accession:  0001213900-24-108617
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

China Pharma enters into up to $600,000 at-the-market equity offering with institutional investor
--------------------------------------------------------------------------------

- SPA signed Dec 12, 2024 for up to $600K of common stock at market price, floor $0.15.
- Commitment period Dec 12 – Dec 31, 2024; investor has sole discretion to purchase.
- Pricing: lower of prior day close or 5-day avg; repricing if delivery delayed; MFN clause for 30 days.
- Investor may return shares within one business day for any reason; no minimum offering amount.
- Shares issued under existing S-3 shelf (File 333-276481); proceeds not determinable.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1106644/000121390024108617/0001213900-24-108617-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1106644/000121390024108617/ea0224537-8k_china.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-108617

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer